|
|
Blood, 15 November 2006, Vol. 108, No. 10, pp. 3580-3589.
Prepublished online as a Blood First Edition Paper on August 1, 2006; DOI 10.1182/blood-2006-03-013334.
Previous Article | Next Article 
Submitted March 28, 2006
Accepted July 7, 2006
Apoptotic cell thrombospondin-1 and heparin binding
domain lead to dendritic cell phagocytic and tolerizing
states
Alon Krispin, Yaniv Bledi, Mizhir Atallah, Uriel Trahtemberg, Inna Verbovetski, Efrat Nahari, Orly Zelig, Michal Linial, and Dror Mevorach*
Hadassah-Hebrew University Medical Center Jerusalem, Israel
Life Science Institute The Hebrew University, Jerusalem, Israel
Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Transfusion Medicine Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
* Corresponding author; email: mevorachd{at}hadassah.org.il.
Apoptotic cells were shown to induce dendritic cell
immune tolerance. We applied a proteomic approach to
identify molecules that are secreted from apoptotic
monocytes, and thus may mediate engulfment and immune
suppression. Supernatants of monocytes undergoing
apoptosis were collected and compared using SDS-PAGE and
differentially expressed proteins were identified using
tandem mass-spectrometry. Thrombospondin-1 (TSP-1) and
its cleaved 26 kDa heparin binding domain (HBD) were
identified. We show that TSP-1 is expressed upon
induction of monocyte apoptosis in a caspase-dependent
pattern and the HBD is cleaved by chymotrypsin-like
serine protease. We further show that CD29, CD36, CD47,
CD51, and CD91 simultaneously participate in engulfment
induction and generation of an iDC tolerogenic and
phagocytic state. We conclude that apoptotic cell TSP-1,
and notably its HBD, creates a signalosome in iDCs to
improve engulfment and to tolerate engulfed material
prior to the interaction with apoptotic cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. B. Maxhimer, D. R. Soto-Pantoja, L. A. Ridnour, H. B. Shih, W. G. DeGraff, M. Tsokos, D. A. Wink, J. S. Isenberg, and D. D. Roberts
Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
Science Translational Medicine,
October 21, 2009;
1(3):
3ra7 - 3ra7.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. del Rio, J.-I. Rodriguez-Barbosa, J. Bolter, M. Ballmaier, O. Dittrich-Breiholz, M. Kracht, S. Jung, and R. Forster
CX3CR1+c-kit+ Bone Marrow Cells Give Rise to CD103+ and CD103- Dendritic Cells with Distinct Functional Properties
J. Immunol.,
November 1, 2008;
181(9):
6178 - 6188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Pallero, C. A. Elzie, J. Chen, D. F. Mosher, and J. E. Murphy-Ullrich
Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis
FASEB J,
November 1, 2008;
22(11):
3968 - 3979.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|